Standardizing the Benefit-Risk Assessment of New Medicines

about

Balancing benefit and risk of medicines: a systematic review and classification of available methodologies.

P2860

Q38211405-0BEBC88E-5330-4108-A288-4E65D7576284

P2860

Standardizing the Benefit-Risk Assessment of New Medicines

Item

http://www.wikidata.org/entity/Q55934009

description

im Juni 2011 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в червні 2011

@uk

name

Standardizing the Benefit-Risk Assessment of New Medicines

@en

Standardizing the Benefit-Risk Assessment of New Medicines

@nl

type

Item

label

Standardizing the Benefit-Risk Assessment of New Medicines

@en

Standardizing the Benefit-Risk Assessment of New Medicines

@nl

prefLabel

Standardizing the Benefit-Risk Assessment of New Medicines

@en

Standardizing the Benefit-Risk Assessment of New Medicines

@nl

P1476

Standardizing the Benefit-Risk Assessment of New Medicines

@en

P2093

James Neil McAuslane

http://www.w3.org/2001/XMLSchema#string

Lawrence Liberti

http://www.w3.org/2001/XMLSchema#string

Stuart Walker

http://www.w3.org/2001/XMLSchema#string

P2860

The effect of alternative summary statistics for communicating risk reduction on decisions about taking statins: a randomized trial

Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma.

Drug harms in the UK: a multicriteria decision analysis.

Medicines regulation and the pharmaceutical industry.

Number needed to treat and number needed to harm are not the best way to report and assess the results of randomised clinical trials.

Weighing benefits and risks--the FDA's review of prasugrel.

Relative efficacy of drugs: an emerging issue between regulatory agencies and third-party payers.

A scale for assessing the severity of diseases and adverse drug reactions. Application to drug benefit and risk.

Regulatory challenges, reimbursement, and risk-benefit assessment.

Using a drug facts box to communicate drug benefits and harms: two randomized trials.

P2888

bf03256855

P304

139-146

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF03256855

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1018093748

http://www.w3.org/2001/XMLSchema#string

Standardizing the Benefit-Risk Assessment of New Medicines

about

P2860

P2860

Standardizing the Benefit-Risk Assessment of New Medicines

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179